Bio-Path Holdings, Inc (BPTH)

Etorro trading 970x250
Bio-Path Holdings, Inc (BPTH) Logo

About Bio-Path Holdings, Inc

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. The company is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas. Address: 4710 Bellaire Boulevard, Bellaire, TX, United States, 77401

Bio-Path Holdings, Inc News and around…

Latest news about Bio-Path Holdings, Inc (BPTH) common stock and company :

Stonegate Capital Partners Updates Coverage On Bio-Path Holdings, Inc. (NASDAQ:BPTH)
20 Sep, 2021 Yahoo! Finance

DALLAS, TX / ACCESSWIRE / September 20, 2021 / Bio-Path Holdings, Inc. (NASDAQ:BPTH): The full report can be accessed by clicking on the following link: http://www.

12 Health Care Stocks Moving In Thursday's After-Market Session
02 Sep, 2021 FinancialContent

Gainers Cellect Biotechnology (NASDAQ:APOP) stock moved upwards by 40.0% to $7.7 during Thursday's after-market session. This ...

12 Health Care Stocks Moving In Monday's After-Market Session
31 Aug, 2021 FinancialContent

Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock moved upwards by 20.91% to $0.68 during Monday's after-market session. Today's ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
25 Aug, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 100.19% to $30.63 during Wednesday's regular session. Regencell ...

Bio-Path (BPTH) to Begin Clinical Study on Leukemia Drug
25 Aug, 2021 Yahoo! Finance

Bio-Path Holdings' (BPTH) IND application for BP1002 receives clearance from the FDA. It is set to begin a phase I/Ib study for treating AML patients. The stock rises following the announcement.

60 Biggest Movers From Yesterday
25 Aug, 2021 FinancialContent

Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding ...

Top Health Care Stocks To Invest In Now? 5 For Your Late 2021 Watchlist
25 Aug, 2021 FinancialContent
12 Health Care Stocks Moving In Tuesday's After-Market Session
24 Aug, 2021 FinancialContent

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 51.24% to $23.14 during Tuesday's after-market session. Regencell Bioscience's ...

Short-Squeeze Stocks: Top 10 Stocks With High Short Interest This Week
24 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Short-squeeze stocks continue to be popular among retail traders as they look for targets to pump higher and we've got a list to watch. The post Short-Squeeze Stocks: Top 10 Stocks With High Short Interest This Week appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

BPTH Stock: The Good News That Has BioPath Investors Smiling Today
24 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips BioPath (BPTH) stock is soaring higher on Tuesday after revealing an update from the FDA on its IND application for BP1002. The post BPTH Stock: The Good News That Has BioPath Investors Smiling Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

12 Health Care Stocks Moving In Tuesday's Intraday Session
24 Aug, 2021 FinancialContent

Gainers Triple-S Management (NYSE:GTS) shares moved upwards by 45.3% to $35.15 during Tuesday's regular session. As ...

PTE Stock: The FDA News That Has Biotech Penny Stock PolarityTE Plunging Today
24 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips PolarityTE (PTE) stock is taking a beating on Tuesday after the biotechnology company got an update from the FDA on its IND. The post PTE Stock: The FDA News That Has Biotech Penny Stock PolarityTE Plunging Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide
24 Aug, 2021 FinancialContent

Midway through trading Tuesday, the Dow traded up 0.09% to 35,368.20 while the NASDAQ rose 0.40% to 15,001.95. The S&P also rose, ...

38 Stocks Moving In Tuesday's Mid-Day Session
24 Aug, 2021 FinancialContent

Gainers Triple-S Management Corporation (NYSE: GTS) shares jumped 45.3% to $35.15. GuideWell Mutual Holding Corporation, parent ...

BPTH Stock: Why Little-Known Bio-Path Holding Just Popped More Than 20%
24 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips BPTH stock is shooting up this morning as the company reveals a new plan for evaluating the effectiveness of one of its drugs. The post BPTH Stock: Why Little-Known Bio-Path Holding Just Popped More Than 20% appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Why Bio-Path Holdings Shares Are Surging Higher Today
24 Aug, 2021 FinancialContent

Bio-Path Holdings Inc (NASDAQ: BPTH) is surging higher Tuesday afterthe company announcedthe U.S Food and Drug ...

Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates
24 Aug, 2021 FinancialContent

Following the market opening Tuesday, the Dow traded up 0.11% to 35,374.12 while the NASDAQ rose 0.43% to 15,006.17. The S&P also ...

Bio-Path Stock Jumps as Leukemia Treatment Candidate Moves to Testing
24 Aug, 2021 Yahoo! Finance

The FDA approves the company's new investigational drug application, allowing it to move to Phase 1/1b clinical stage.

Why Bio-Path Shares Are Moving Higher In Premarket Tuesday?
24 Aug, 2021 FinancialContent

TheFDA has signed offBio-Path Holdings Inc's(NASDAQ: BPTH) Investigational New Drug (IND) application for ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
24 Aug, 2021 FinancialContent

Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. ...

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
24 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients
24 Aug, 2021 FinancialContent

Phase 1/ 1b Clinical Trial to Evaluate Ability of BP1002, Targeting Bcl-2 Protein, to Treat Refractory/Relapsed AML Patients

Stock Market News For Today August 13, 2021
13 Aug, 2021 FinancialContent
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
13 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Bio-Path Holdings Reports Second Quarter 2021 Financial Results
13 Aug, 2021 FinancialContent

Conference Call to be Held Today at 8:30 A.M. ET

Earnings Scheduled For August 13, 2021
13 Aug, 2021 FinancialContent

Companies Reporting Before The Bell • Jaguar Health (NASDAQ:JAGX) is expected to report quarterly loss at $0.03 per ...

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
08 Aug, 2021 FinancialContent

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader ...

Bio-Path Holdings to Announce Second Quarter 2021 Financial Results on August 13, 2021
06 Aug, 2021 FinancialContent
Why Moderna, Bio-Path Holdings And vTv Therapeutics Are Moving Today
22 Jun, 2021 FinancialContent

Moderna, Inc. (NASDAQ: MRNA), Bio-Path Holdings, Inc. (NASDAQ: BPTH) and vTv Therapeutics Inc. (NASDAQ: VTVT) are among the biggest ...

Bio-Path Granted Key Mechanism of Action U.S. Patent for BP1003
22 Jun, 2021 FinancialContent

Provides Protection and Highlights Novelty of BP1003 to Inhibit STAT3 Expression in a Variety of Difficult to Treat Cancers

Bio-Path Holdings, Inc (BPTH) is a NASDAQ Common Stock listed in , ,

970x250